1. Home
  2. SPRO vs DLTH Comparison

SPRO vs DLTH Comparison

Compare SPRO & DLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.20

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$4.33

Market Cap

138.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
DLTH
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
156.3M
138.0M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
SPRO
DLTH
Price
$1.20
$4.33
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
2.0M
91.4K
Earning Date
05-13-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
64.12
EPS
N/A
N/A
Revenue
$66,802,000.00
$565,184,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
$2.80
P/E Ratio
N/A
N/A
Revenue Growth
39.24
N/A
52 Week Low
$1.08
$2.02
52 Week High
$3.08
$5.09

Technical Indicators

Market Signals
Indicator
SPRO
DLTH
Relative Strength Index (RSI) 22.37 53.34
Support Level N/A $3.95
Resistance Level $2.44 $4.76
Average True Range (ATR) 0.16 0.21
MACD -0.05 -0.02
Stochastic Oscillator 10.32 52.50

Price Performance

Historical Comparison
SPRO
DLTH

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

Share on Social Networks: